As Germany’s COVID vaccine mandate is delayed, beware anyone who says the issue has easy answers

Amid SEC battle, crypto company Ripple Labs buys back its Series C investment

In an unusual move for a startup, the cross-border payments company has taken its governance and dividends rights back—for a premium. Read More

Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More

Google Health is being dismantled, but Big Tech’s quixotic health ambitions persist

Google is dismantling its unified health care division Google Health as division head David Feinberg departs. But it won’t stop Big Tech’s quixotic quest to transform American healthcare. Read More